Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Zhejiang Jolly Pharmaceutical Co.,LTD
  6. Summary
    300181   CNE100001096

ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD

(300181)
  Report
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
8.13 8.16 8.13 8.32 8.26 Last
7573636 11412100 8274200 14510030 10222970 Volume
+0.99% +0.37% -0.37% +2.34% -0.72% Change
Estimated financial data (e)
Sales 2019 911 M 143 M 143 M
Net income 2019 25,6 M 4,01 M 4,01 M
Net Debt 2019 218 M 34,1 M 34,1 M
P/E ratio 2019 120x
Yield 2019 0,40%
Sales 2020 1 091 M 171 M 171 M
Net income 2020 88,8 M 13,9 M 13,9 M
Net Debt 2020 33,1 M 5,19 M 5,19 M
P/E ratio 2020 40,4x
Yield 2020 1,69%
Capitalization 5 027 M 787 M 788 M
EV / Sales 2019 3,61x
EV / Sales 2020 3,32x
Nbr of Employees 1 991
Free-Float 49,2%
More Financials
Company
Zhejiang Jolly Pharmaceutical Co., Ltd. is a China-based company principally engaged in research, development, manufacture and sales of medicinal fungi series products. The CompanyÔÇÖs main business is mainly involved in pharmaceutical manufacturing, among which the activities are involved in manufacture and sale of active pharmaceutical ingredients, tablets, capsules, granules, Lyophilized powders and other... 
Sector
Pharmaceuticals
Calendar
04/14Earnings Release
More about the company
All news about ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD
10/26Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ende..
CI
09/07Exclusive-China's top property broker KE Holdings exploring Hong Kong listing - sources
RE
07/27Zhejiang Jolly Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended ..
CI
05/25Zhejiang Jolly Pharmaceutical Co.,Ltd Announces Final Cash Dividend for 2020, Payable o..
CI
05/20Zhejiang Jolly Pharmaceutical Co.,Ltd Approves Dividend for the Year 2020
CI
04/26Zhejiang Jolly Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter En..
CI
04/13Zhejiang Jolly Pharmaceutical Co.,Ltd Proposes Final Cash Dividend for 2020
CI
04/12Zhejiang Jolly Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended ..
CI
01/26Zhejiang Jolly Pharmaceutical Co.,LTD Approves Management Appointments
CI
2020Deqing County Cultural Tourism Development Group Co., Ltd. completed the acquisition of..
CI
2020Zhejiang Jolly Pharmaceutical Co.,LTD agreed to acquire 20% stake in Zhejiang Jolly Bai..
CI
2020Zhejiang Jolly Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ende..
CI
2020Deqing County Cultural Tourism Development Group Co., Ltd. signed a share transfer agre..
CI
2020Zhejiang Jolly Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended ..
CI
2020Zhejiang Jolly Pharmaceutical Co.,LTD Announces 2019 Final Distribution Plan to Be Impl..
CI
More news
News in other languages on ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD

- No features available -

More news
Chart ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD
Duration : Period :
Zhejiang Jolly Pharmaceutical Co.,LTD Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Managers and Directors
Tao Wang General Manager
Guo Fen Chen Chief Financial Officer & Deputy General Manager
You Qiang Yu Chairman
Cheng Hua Zhou Chairman-Supervisory Board
Bin Pan Independent Director